Immunogenicity and safety of two priming doses of an MF59-adjuvanted cell-based H5N8 influenza vaccine in healthy persons aged ≥18 years
- DOI
- 10.1016/j.vaccine.2026.129279
- Published
- 2027-01
- Container
- Vaccine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.vaccine.2026.129279,
title = {Immunogenicity and safety of two priming doses of an MF59-adjuvanted cell-based H5N8 influenza vaccine in healthy persons aged ≥18 years},
author = {Adam Brosz and Janine Oberije and Eve Versage and Arik Elfassy and Derchieh Hung and Matt Hohenboken},
year = {2027},
journal = {Vaccine},
doi = {10.1016/j.vaccine.2026.129279},
url = {https://doi.org/10.1016/j.vaccine.2026.129279}
}RIS
TY - JOUR TI - Immunogenicity and safety of two priming doses of an MF59-adjuvanted cell-based H5N8 influenza vaccine in healthy persons aged ≥18 years AU - Adam Brosz AU - Janine Oberije AU - Eve Versage AU - Arik Elfassy AU - Derchieh Hung AU - Matt Hohenboken PY - 2027 JO - Vaccine DO - 10.1016/j.vaccine.2026.129279 UR - https://doi.org/10.1016/j.vaccine.2026.129279 ER -
APA
Brosz, A., Oberije, J., Versage, E., Elfassy, A., Hung, D., & Hohenboken, M. (2027). Immunogenicity and safety of two priming doses of an MF59-adjuvanted cell-based H5N8 influenza vaccine in healthy persons aged ≥18 years. Vaccine. https://doi.org/10.1016/j.vaccine.2026.129279
Source records
- crossref · retrieved 2026-11-09T10:41:28.502Z